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PUBLIC AVAILABILITY OF PUBLISHED RESEARCH DATA IN 
SUBSTANCE ABUSE JOURNALS 
 
ABSTRACT 
 
Sharing research data is an increasingly necessary requirement for the advancement of 
science. The aim of this study was to analyse the policies on openness in sharing 
scientific research data in substance abuse journals. Journals included in the Substance 
abuse area of the Journal Citation Reports were used for the analysis, with reference to 
the instructions to authors published on the journals’ websites. In 67.6% of the journals, 
it is possible to store materials in thematic or institutional repositories; 47% accept 
supplemental material; 64.7% allow the reuse of data, and 41.2% admit the publication 
of their data on a website. Most journals recommend that authors deposit their data in a 
repository, but they do not provide clear instructions for doing so. A correlation was 
found between the value of a journal’s impact factor and the storage and reuse. PubMed 
Central is the repository primarily suggested for deposit. 
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BACKGROUND 
 
Substance abuse is an economic, political and social problem that encompasses the 
entire population and is experiencing a gradual normalisation in consumption. However, 
substance abuse remains a major public health problem globally. Data from the World 
Health Organization show that the harmful use of alcohol causes 2.5 million deaths each 
year, with 9% of the deaths occurring in individuals aged 15 to 29 years old. It is also 
estimated that at least 15.3 million people suffer from addictive disorders of various 
types, and one in twenty adults consumed illegal substances at least once during 2010. 
However, the resources devoted to treatment are not sufficient to address the problem 
because they are intended for only 1.7 beds per 100,000 inhabitants and only 30% of 
countries have effective medication [1]. 
 
In this situation, access to all information on all aspects of the problem takes on an 
importance for professionals working or researching in this field. Within the traditional 
system of publishing research data, only a small fraction of the data is available to the 
public, and in addition, the selection of these data depends on the value that the authors 
give to the published article [2-4].  
 
Today, funding agencies and many researchers agree that raw data on which the 
research is based should be disseminated freely for future use. Therefore, scientists are 
increasingly encouraged to offer their data for public access, regardless of whether these 
data are associated with a publication. One such institution, the Royal Society, insists in 
its report entitled "Science as an open enterprise report" on the urgent need to provide 
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public access to data, which means that they are easily locatable, interpretable, reusable 
and citable [5]. 
 
Scientific journals are the current system of research publication and play an important 
role in this process because current technology allows for the deposit of data and 
supplementary materials accompanying the published work [6]. However, the rules on 
the publication of raw data in substance related disorder journals are largely unknown. 
The aim of the current study is to analyse the open-data policies of the scientific 
research journals listed in the Substance abuse area of the Journal Citation Reports. 
 
 
METHODS 
 
 
We reviewed the websites of the 34 journals included in the Substance abuse category 
of the Journal Citation Reports (Science and Social Science editions), referring 
specifically to the instructions to authors. For each journal, we documented the policies 
related to public availability of data sharing, where available. 
 
The following data were collected for each journal: a) Journal name; b) Publisher; c) 
Journal website; d) Storage in thematic or institutional repositories, including the 
following variables: A: Accepted, when the supplementary material can be deposited in 
institutional or thematic repositories and also when deposit in public repositories is 
required for publication in the journal; NA: Not Accepted, when explicit deposit in any 
repository is not allowed; NS: Not Specified, when there is no clear information on 
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deposit in a repository; e) Statement of policy regarding complementary material (A; 
NA; NS); f) Reuse policy (A; NA; NS); and g) Policy regarding data publication on the 
official website or by the author (N; NA; NS). This information was collected from July  
2013 to September 2013. 
 
 
RESULTS 
 
 
Table 1 presents the results obtained in accordance with the four main variables 
analysed. In relation to the variable "Storage in thematic or institutional repositories", 
67.6% of the journals specified that it was possible, whereas 32.4% did not specify such 
a possibility. The percentage was higher for journals included in the first quartile by an 
impact factor in the JCR substance abuse area, but the percentage of journals that did 
not specify this information was higher in the fourth quartile journals. That option was 
not denied by any journal. 
 
TABLE 1 ABOUT HERE 
 
The variable "Statement of complementary material" was accepted in 47% of the 
journals, whereas 53% did not specify a preference. The results were quite similar in all 
of the quartiles. 
 
The following results were obtained regarding the reuse of data: 64.7% of the journals 
support this possibility and the remaining 35.3% did not specify. The highest percentage 
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of response across this variable was in the journals of the first quartile that accept the 
reuse of data. 
 
The variable regarding the possibility of publishing data on a website presented the 
following results: 41.2% of the journals accepted it, 38.2% did not specify a policy on 
this option and 20.6% did not allow it. 
 
The 43 journals included in the study are published by 18 different publishing 
companies or institutions (Table 2), of which 12 (35.3%) publish only one journal. The 
institution that publishes the most substance abuse journals is Informa Healthcare (n=6), 
followed by Routledge Journals, Taylor & Francis Ltd (n=5) and Wiley-Blackwell 
(n=5). Within each publishing entity, the policies on depositing data in repositories are 
variable. In four publishing entities that publish eight journals (23.5%), PubMed Central 
is specified as the repository. In eight publishing entities that publish 14 journals 
(41.2%), no repository was advised. In one journal, the recommended repositories were 
related to clinical trial registries, including Australian New Zealand Clinical Trials 
Registry, Clinical Trials, ISRCTN Register, Netherlands Trial Register, and UMIN 
Clinical Trial Register. Finally, three indicated the possibility to deposit data into 
repositories, but without specifying any locations. Biomed Central LTD, with two 
journals, is considered an open access repository.     
 
TABLE 2 ABOUT HERE 
 
DISCUSSION 
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This paper analyses open-data policies for 34 journals listed in the Substance abuse area 
of Journal Citation Reports and has allowed for the identification of some 
characteristics concerning these policies. 
 
There are several advantages of data sharing for both researchers depositing data and 
researchers who reuse these data. Data sharing increases transparency in the 
presentation of research results and data because researchers can reproduce the 
experiments and test hypotheses [7]. It helps to avoid duplication of projects with 
similar objectives. Data sharing also generates opportunities for additional publications 
through collaboration [8]. The original researcher who deposited data can also benefit 
from new data added and placed by other researchers, while data sharing enables 
collaboration with other researchers attracted by the availability of shared data [3], 
further studies and meta-analyses [9]. Health care organisations that adopt the goals of 
data sharing are more attractive to advanced researchers and therefore more able to 
recruit the talent needed for future success, which will result in increasing excellence 
[10]. It has been said that data sharing increases visibility and relevance of the work and 
the number of citations received in later papers [11]. Data sharing is particularly 
important in substance abuse research because underutilising or not utilising all of the 
available data can lead to the unnecessary exposure of individuals participating in 
clinical trials for which data already exist [12,13]. Although most of the published 
studies on this topic speak in favour of the benefits of sharing, some disagree with this 
direction, arguing the fear of misuse of data, loss of intellectual property and 
confidentiality issues [14]. Some researchers also argue that exchanging data introduces 
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an additional risk to subjects because the danger of losing the protection of privacy is 
greater once the data have been shared. Researchers who reuse the data may not 
maintain the same zeal in protecting the subjects as the original investigators, although 
they are bound by science to this legal and ethical responsibility [3,9,14]. 
 
Scientific institutions increasingly show a greater interest in data sharing. The U.S. 
Government, through the Substance Abuse and Mental Health Services Administration 
(SAMHSA), provides the Substance Abuse and Mental Health Data Archive portal 
(SAMHDA), whose National Addiction & HIV Data Archive Program (NAHDAP) has 
the aim to facilitate research on drug addiction and HIV infection by acquiring, 
enhancing, preserving, and sharing data produced by research grants, particularly those 
funded by the National Institute on Drug Abuse (NIDA) [15]. NAHDAP supports 
secondary data analysis through technical assistance and specialised training for data 
depositors and data users in the drug addiction and HIV research and policy 
communities. NAHDAP provides services to assist data depositors (technical assistance 
with data preparation, enhancing secondary use; educational activities to promote data 
sharing; proposal preparation and data sharing plans; and confidentiality reviews of 
data), Data User Services (online analysis of selected data through online Survey 
Documentation and Analysis; assistance with retrieval and use of data files from 
NAHDAP; bibliographic citations to publications based on research data in NAHDAP) 
and Education and Training Services (workshops; webinars on data preparation and 
legal and technical issues associated with data sharing; conference short courses on data 
management plans and data sharing; on-site technical training for depositors and 
research work groups to enhance data preparation). The European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA), which is the reference point on drugs and 
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drug addiction information in Europe, also has a reusing data policy. The information 
provided by EMCDDA may be freely reused and reproduced accurately, but not 
presented in a misleading way, and all sources must be acknowledged [16].  
 
As seen, the most recommended repository for data deposit and sometimes the only one 
mentioned is PubMed Central, the digital repository of biomedical literature operated by 
the National Library of Medicine. An example of the current importance of this 
repository is the number of items included on drug dependence. With the Medical 
Subject Heading (MeSH) "Substance-Related Disorders", we recovered 20,887 items in 
January 2014. Applying the limit "Articles with Supplementary Material", 1,219 items 
were obtained. Though this value represents only 5.8% of the total, the growth has been 
very strong in recent years, rising from 131 in 2008 (10.7%) to 313 in 2012 (25.7%). 
Following the example of PubMed Central, it is necessary to create institutional and 
subject repositories of data that allow researchers to deposit their data there, with 
appropriate counselling and the necessary guarantees of safeguard.  
 
One of the limitations of this study is that it analyses only substance abuse journals 
included in the JCR and it is possible that different policies exist regarding other 
journals. However, these journals were chosen because they have a great diffusion 
through the WOS as well as international impact. The data obtained can thus serve as a 
reference for subsequent studies. 
 
Conclusions 
 
 10 
 
Most of the journals support the possibility of data storage in thematic or institutional 
repositories. Journals accept additional material and reuse of data, but most of them 
have no specific instructions for authors to follow and present uncertainty as to the 
possibility of publishing the data on a website. There is no relationship between 
openness policies and the impact of the journals according to their quartile or position 
ranking by impact factor in the JCR. Deposit policies vary among publishing entities, 
with PubMed Central and repositories of clinical trials among those predominantly 
suggested for data deposit. The dispersed and multidisciplinary nature of international 
research networks on drug addiction is an argument in favour of open-data by allowing 
reuse by multiple researchers for a variety of purposes. Future work along these lines 
could analyse policies in other journals not included in WOS as well as the practices 
and perceptions of specialists in substance abuse regarding data accessibility, reuse, 
preservation and data sharing in an effort to identify barriers to effective data sharing. 
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Table 1. Results from main variables analyzed 
Q
* 
Storage in thematic or 
institutional repositories 
Statement of 
complementary material 
Reuse Publication in website 
A NA NS A NA NS A NA NS A NA NS 
N  
(%) 
N  
(%) 
N  
(%) 
N  
(%) 
N  
(%) 
N  
(%) 
N  
(%) 
N  
(%) 
N  
(%) 
N  
(%) 
N 
(%) 
N  
(%) 
1 8  
88,8% 
- 1  
11,2% 
4  
44,4% 
- 5  
55,6% 
8  
88,8% 
- 1  
11,2% 
3  
33,3% 
1  
11,1% 
5  
55,6% 
2 6  
75% 
- 2  
25% 
4  
50% 
- 4  
50% 
6  
75% 
- 2  
25% 
3  
37,5% 
1  
12,5% 
4  
50% 
3 6  
66,7% 
- 3  
33,3% 
4  
44,4% 
- 5  
55,6% 
5  
55,6% 
- 4  
44,4% 
7  
77,8% 
2  
22,2% 
- 
4 3  
37,5% 
- 5  
62,5% 
4  
50% 
- 4  
50% 
3  
37,5% 
- 5  
62,5% 
1  
12,5% 
3  
37,5% 
4  
50% 
* Q: Quartil in Substance Abuse category in Journal Citation Reports SCI and SSCI. In 
case of simultaneous presence in both editions the highest Rank was selected.  
(A: Accepted; NA: Not Accepted; NS: Not Specified) 
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Table 2. Recommended repositories from publishers 
Publishers Nº 
journals 
Journals Recommended repositories 
Alcohol Res 
Documentation Inc 
Cent Alcohol Stud 
Rutgers Univ 
1 - Journal of Studies 
on  Alcohol and 
Drugs 
PubMed Central 
Baywood Publ Co Inc 1 - Journal of Drug 
Education 
Do not recommend any 
repository 
Biomed Central Ltd  2 - Harm Reduction 
Journal 
- Substance Abuse 
Treatment, 
Prevention, and 
Policy 
It’s an open access 
repository 
Educational Publishing 
Foundation-American 
Psychological 
Association 
1 - Psychology of 
Addictive 
Behaviors 
Depending on the deposit 
requirements of your 
research funding agency, 
the APA will deposit either 
the accepted peer-reviewed 
manuscript or the final 
Elsevier Ireland Ltd 1 - Drug and Alcohol 
Dependence 
Australian New Zealand 
Clinical Trials Registry; 
Clinical Trials; ISRCTN 
Register; Netherlands Trial 
Register; UMIN Clinical 
Trials Registry 
Elsevier Science 2 - International 
Journal of Drug 
Policy 
- Alcohol 
Do not recommend any 
repository 
Informa Healthcare 6 - American Journal 
on Drug and 
Alcohol Abuse 
- Substance Use & 
Misuse  
- Addiction 
Research & 
Theory 
- Journal of 
Addictions 
Nursing 
- Drugs: Education, 
Prevention, and 
Policy 
- Journal of 
Substance Use 
Informa Healthcare 
requests, as a consideration 
of publication, that clinical 
trials are registered in a 
public repository at their 
inception and prior to 
patient 
Journal of Drug Issues 
Inc 
1 - Journal of Drug 
Issues 
Do not recommend any 
repository 
Karger 1 - European PubMed Central 
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Addiction 
Research 
Lippincott Williams & 
Wilkins 
1 - Journal of 
Addiction 
Medicine 
PubMed Central 
Natl Inst Alcohol 
Abuse Alcoholism 
1 - Alcohol Research 
& Health 
Do not recommend any 
repository 
Oxford Univ Press 1 - Alcohol & 
Alcoholism 
Institutional and/or centrally 
organized repositories 
Pacini Editore 1 - Heroin addiction 
and related clinical 
problems 
Do not recommend any 
repository 
Pergamon-Elsevier 
Science ltd 
2 - Journal of 
Substance Abuse 
Treatment 
- Addictive 
Behaviors 
Do not recommend any 
repository 
Routledge Journals, 
Taylor & Francis ltd 
5 - Journal of 
Addictive 
Diseases 
- Substance Abuse 
- Journal of 
Psychoactive 
Drugs 
- Journal of Dual 
Diagnosis 
- Journal of Child & 
Adolescent 
Substance Abuse 
Do not recommend any 
repository 
Socidrogalcohol 1 - Adicciones Do not recommend any 
repository 
Springer 1 - Journal of 
Gambling Studies 
Open access repositories 
Wiley-Blackwell 5 - Addiction Biology 
- Addiction 
- Alcoholism: 
Clinical and 
Experimental 
Research 
- The American 
Journal on 
Addictions 
- Drug and Alcohol 
Review 
PubMed Central 
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